REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice.

Pharm Res · 2026 · PMC13179201 · PMID 41792506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Serum BUN levels showed a decreasing trend in all REAL208-treated groups, with the most notable reduction observed in the 50 mg/kg group (from 37.1 ± 1.7 to 26.9 ± 5.1 mg/dL), indicative of the absence of renal burden.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.